BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31167247)

  • 1. Immunomodulatory Second-Line Therapies for Immune Thrombocytopenia.
    Lambert MP
    Hamostaseologie; 2019 Aug; 39(3):266-271. PubMed ID: 31167247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ITP and AIHA in CVID: A systematic literature review].
    Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
    Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of treatments for adults with primary immune thrombocytopenia.
    George JN
    Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of primary immune thrombocytopenia in adults.
    Ejaz A; Radia D
    Br J Hosp Med (Lond); 2019 Apr; 80(4):C54-C57. PubMed ID: 30951423
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current treatment of primary immune thrombocytopenia].
    Lozano ML; Vicente V
    Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging treatments for immune thrombocytopenia.
    Dou X; Yang R
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [No Abstract]   [Full Text] [Related]  

  • 8. New options after first-line therapy for chronic immune thrombocytopenic purpura.
    Burzynski J
    Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S11-21. PubMed ID: 19139486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenia: no longer 'idiopathic'.
    McCrae K
    Cleve Clin J Med; 2011 Jun; 78(6):358-73. PubMed ID: 21632906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
    Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J
    J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
    Kuter DJ; Mathias SD; Rummel M; Mandanas R; Giagounidis AA; Wang X; Deuson RR
    Am J Hematol; 2012 May; 87(5):558-61. PubMed ID: 22460421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
    Kohli R; Chaturvedi S
    Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune thrombocytopenia in adults: an update.
    Thota S; Kistangari G; Daw H; Spiro T
    Cleve Clin J Med; 2012 Sep; 79(9):641-50. PubMed ID: 22949345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
    Depré F; Aboud N; Mayer B; Salama A
    PLoS One; 2018; 13(6):e0198184. PubMed ID: 29856800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and Therapy of Immune thrombocytopenia].
    Matzdorff A; Wörmann B
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
    Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
    Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy for immune thrombocytopenia: down but not out.
    Chaturvedi S; Arnold DM; McCrae KR
    Blood; 2018 Mar; 131(11):1172-1182. PubMed ID: 29295846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.